Life Technologies Forms Team to Focus on IP Licensing for PCR, other Products | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies officials said this week that the company has formed a licensing team that will focus on offsetting declining royalty revenues for its PCR-related intellectual property and other IP.

During a conference call to discuss the company's third-quarter financial results, Life Tech Chairman and CEO Greg Lucier said that the company has assembled a team of the "best licensing people" from its Applied Biosystems and Invitrogen businesses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.